Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5425)
All Articles published online
|
Publishing Process of This Article
|
Apr 26, 2021 (publication date) through May 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sun G, Zhuang W, Lin QT, Wang LM, Zhen YH, Xi SY, Lin XL. Partial response to Chinese patent medicine Kangliu pill for adult glioblastoma: A case report and review of the literature. World J Clin Cases 2021; 9(12): 2845-2853 [PMID: 33969068 DOI: 10.12998/wjcc.v9.i12.2845] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v9/i12/2845.htm |
| Number | Citing Articles |
| 1 |
Fei Chen, Jing-Jing Cui, De-Chun Jiang, Hai-Zheng Wang, Wei Zhuang, Ying-Nan Feng, Xiao-Lan Lin, Sheng-Yan Xi. Antitumor mechanism of kangliu pill on gliomas in mice through PI3K-Akt signaling pathway. Journal of Ethnopharmacology 2023; 307: 116252 doi: 10.1016/j.jep.2023.116252
|